Terms: = Prostate cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Diagnosis
23 results:
1. Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
J Geriatr Oncol; 2024 Apr; 15(3):101748. PubMed ID: 38493533
[TBL] [Abstract] [Full Text] [Related]
2. Estimation of the Number of Individuals Living With Metastatic cancer in the United States.
Gallicchio L; Devasia TP; Tonorezos E; Mollica MA; Mariotto A
J Natl Cancer Inst; 2022 Nov; 114(11):1476-1483. PubMed ID: 35993614
[TBL] [Abstract] [Full Text] [Related]
3. One-Step Thermophoretic AND Gate Operation on Extracellular Vesicles Improves diagnosis of prostate cancer.
Deng J; Zhao S; Li J; Cheng Y; Liu C; Liu Z; Li L; Tian F; Dai B; Sun J
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202207037. PubMed ID: 35749531
[TBL] [Abstract] [Full Text] [Related]
4. The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Yuan XH; Wang JJ; Wang YC; Li SL
Medicine (Baltimore); 2020 May; 99(22):e19993. PubMed ID: 32481368
[TBL] [Abstract] [Full Text] [Related]
5. arnt-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Chen G; Cai ZD; Lin ZY; Wang C; Liang YX; Han ZD; He HC; Mo RJ; Lu JM; Pan B; Wu CL; Wang F; Zhong WD
Mol Carcinog; 2020 Aug; 59(8):897-907. PubMed ID: 32319143
[TBL] [Abstract] [Full Text] [Related]
6. Association between depression and healthcare expenditures among elderly cancer patients.
Gu D; Morgan RO; Li R; Weber ES; Shen C
BMC Psychiatry; 2020 Mar; 20(1):131. PubMed ID: 32293366
[TBL] [Abstract] [Full Text] [Related]
7. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
Sathianathen NJ; Philippou YA; Kuntz GM; Konety BR; Gupta S; Lamb AD; Dahm P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012816. PubMed ID: 30320443
[TBL] [Abstract] [Full Text] [Related]
8. The association of renal cell carcinoma with gastrointestinal stromal tumors.
Mendonca SJ; Sanchez A; Blum KA; Ghanaat M; Kashan MY; Benfante N; Russo P; Coleman JA; Crago AM; Hakimi AA
J Surg Oncol; 2018 Jun; 117(8):1716-1720. PubMed ID: 29878354
[TBL] [Abstract] [Full Text] [Related]
9. Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.
Nakai Y; Miyake M; Anai S; Hori S; Tatsumi Y; Morizawa Y; Onisi S; Tanaka N; Fujimoto K
Lasers Med Sci; 2018 Sep; 33(7):1557-1563. PubMed ID: 29725946
[TBL] [Abstract] [Full Text] [Related]
10. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract] [Full Text] [Related]
11. All-Cause Mortality for Life Insurance Applicants with a History of prostate cancer.
Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
[TBL] [Abstract] [Full Text] [Related]
12. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
[TBL] [Abstract] [Full Text] [Related]
13. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.
Seal B; Sullivan SD; Ramsey SD; Asche CV; Shermock K; Sarma S; Zagadailov EA; Farrelly E; Eaddy M
Appl Health Econ Health Policy; 2014 Oct; 12(5):547-57. PubMed ID: 25005491
[TBL] [Abstract] [Full Text] [Related]
14. Common cancers in centenarians.
Joseph SC; Delcastilo E; Loukas M; Osiro S
Med Sci Monit; 2014 Jan; 20():18-23. PubMed ID: 24399367
[TBL] [Abstract] [Full Text] [Related]
15. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the performance of tests for spatial randomness on prostate cancer data.
Hinrichsen VL; Klassen AC; Song C; Kulldorff M
Int J Health Geogr; 2009 Jul; 8():41. PubMed ID: 19575788
[TBL] [Abstract] [Full Text] [Related]
17. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract] [Full Text] [Related]
18. Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases.
Chu PG; Huang Q; Weiss LM
Am J Surg Pathol; 2005 May; 29(5):693-9. PubMed ID: 15832096
[TBL] [Abstract] [Full Text] [Related]
19. Dietary patterns and risk of prostate cancer in Ontario, Canada.
Walker M; Aronson KJ; King W; Wilson JW; Fan W; Heaton JP; MacNeily A; Nickel JC; Morales A
Int J Cancer; 2005 Sep; 116(4):592-8. PubMed ID: 15825170
[TBL] [Abstract] [Full Text] [Related]
20. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening.
Gattellari M; Ward JE
J Med Screen; 2004; 11(4):165-9. PubMed ID: 15563771
[TBL] [Abstract] [Full Text] [Related]
[Next]
